THERAPEUTIC AND/OR PROPHYLACTIC AGENT FOR LEWY BODY DISEASE
The present invention provides a therapeutic and/or prophylactic agent and the like, comprising istradefylline as an active ingredient, for Lewy body disease (for example, Parkinson's disease dementia, diffuse Lewy body disease, dementia with Lewy bodies, movement disorder associated with Lewy body disease and the like).
1 - 5 . (canceled)
6 . A method for treating and/or preventing Lewy body disease, comprising:
administering an effective amount of istradefylline to a subject.
7 . The method of claim 6 , wherein the Lewy body disease is Parkinson's disease dementia.
8 . The method of claim 6 , wherein the Lewy body disease is diffuse Lewy body disease.
9 . The method of claim 6 , wherein the Lewy body disease is dementia with Lewy bodies.
10 . The method of claim 6 , wherein the Lewy body disease is movement disorder associated with Lewy body disease.
11 . The method of claim 6 , wherein the method is for treating the Lewy body disease.